Libtayo (cemiplimab) for advanced basal cell carcinoma
Article written by Christine Clark At present there are no approved treatments for advanced basal cell carcinoma, a condition that is estimated to affect about 20,000 US patients… read more.
Article written by Christine Clark At present there are no approved treatments for advanced basal cell carcinoma, a condition that is estimated to affect about 20,000 US patients… read more.
Article written by Christine Clark Two recent systematic reviews have examined the use of masks
The European Medicines Agency’s (EMA) human medicines committee (CHMP) has recommended eight medicines for approval at its June 2020 meeting.
Global regulators have held a workshop designed to nail down the data they will require of companies developing vaccines against COVID-19.
The European Medicines Agency will welcome a new Executive Director by the end of 2020. The change comes as the EU drug watchdog’s current chief, Guido Rasi, is… read more.
Article written by Bruce Sylvester
Article written by Bruce Sylvester
The majority of patients with follicular lymphoma (FL) have excellent results when treated with chemotherapy so — even with evolving understanding of disease biology and availability of a parade… read more.
Professor Stephen Ansell (Rochester, USA) discusses the DIAL study
Dr Graham Collins (Oxford, UK) discusses real-world data from patients treated with CD19 CAR-T in England. He then reviews data presented on the risk of fracture following front-line R-CHOP… read more.
Dr Steven Horwitz (New York, USA) discusses new directions for treating PTCL. Written by Thomas R. Collins.